Neuodevelopmental outcomes for children transplanted under the age of 3 years

D M Thevenin1, A Baker, T Kato

  • 1Department of Pediatrics, UMMG Physician-Patient Advocacy Program, University of Miami/Miller School of Medicine, Miami, FL 33101, USA. dthevenin@med.miami.edu

Insights

Infants undergoing intestinal or multivisceral transplants show significantly poorer neurodevelopmental outcomes compared to liver transplant recipients. Early organ transplant type impacts infant brain development and long-term cognitive and motor skills.

Area of Science:

  • Pediatric Gastroenterology
  • Neurodevelopmental Pediatrics
  • Transplant Surgery

Background:

  • Previous studies indicated neurodevelopmental challenges in intestinal transplant recipients.
  • Infants transplanted before age 3 are particularly vulnerable due to potential impacts of chronic illness and malnutrition on brain development.

Purpose of the Study:

  • To compare neurodevelopmental outcomes in infants undergoing intestinal/multivisceral transplants versus liver transplants.
  • To investigate the influence of transplant type on cognitive and motor development in young children.

Main Methods:

  • Evaluated 34 infants using the Bayley Scales of Infant Development.
  • Compared outcomes between 27 children receiving liver/intestine or multivisceral transplants and 7 children receiving liver transplants.

Main Results:

  • Intestine/multivisceral transplant recipients exhibited significantly higher rates of mental delay (74%) compared to liver transplant recipients (57.14%).
  • Motor development was severely delayed in 96.3% of intestine/multivisceral transplant infants versus 71% of liver transplant infants.
  • Liver transplant infants had a higher likelihood of normal neurodevelopmental functioning (42.86%) post-transplant.

Conclusions:

  • The type of organ transplant significantly influences neurodevelopmental outcomes in infants.
  • Liver transplant recipients generally experience better cognitive and motor development compared to intestine/multivisceral transplant recipients.
  • Disease severity and early nutritional deficits may contribute to poorer outcomes in intestinal and multivisceral transplant patients.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...